SAH have indicated that the most prominent process taking place in the cerebrospinal fluid (CSF) is the hemolysis of blood clots (8, 17, 22) . After hemolysis, vasoactive agents accumulate in the CSF, leading to increased levels of 5-hydroxytryptamine (5-HT), lysophosphatidic acid (LPA), thromboxane, oxyhemoglobin, etc. (14, 17, 22, 28, 40) . These substances that are released by clotting blood and during hemolysis of blood clots are known to have contractile properties and can stimulate the production of other potent constrictor agents (8, 10, 15, 22, 30, (33) (34) (35) (36) (37) 40) . Vasoactive agents can interact with cerebral microvessels to produce structural changes along with alteration of cerebral microvascular responses to dilator and constrictor stimuli (9, 10, 15, 23, 24) . The changes in cerebral microvascular responses and metabolism induced by breakdown products of blood clots may be mediated via the regulation of second messenger systems which include protein kinase C (PKC), intracellular calcium concentration ([Ca 2ϩ ] i ), inositol trisphosphate (IP 3 ), and diacylglycerol (DAG).
Intracellular Ca 2ϩ signals have been implicated in the regulation of cellular functions such as production and release of many vasoactive factors (e.g., ET-1) under physiological and pathological conditions. Ca 2ϩ signals may be triggered via Ca 2ϩ channels such as receptor-activated, store-operated, capacitative Ca 2ϩ entry or voltage-operated Ca 2ϩ channels (20) . Of these channels, voltage-operated channels are designated as the most important in the regulation of cellular functions, especially in the synthesis and release of vasoactive factors (4, 20) . However, expressions of voltageoperated Ca 2ϩ channels in endothelial cells have been a matter of controversy and debate (19) , and the role of voltage-operated Ca 2ϩ channels and intracellular Ca 2ϩ in the biosynthesis and release of ET-1 from cerebral microvascular endothelial cells is not clear.
ET-1 is the most potent naturally occurring vasoconstrictor agent known (13, 28, (33) (34) (35) (36) (37) (38) (39) and has been implicated in the consequences of hemorrhage-induced alteration of cerebral microcirculation and the development of cerebral vasospasm (8, 15, 28, 33, 36) . Vasoactive factors released from blood clotting and hemo-lysis have been reported to stimulate ET-1 production from vascular cells (8, 14, 17, 30, 35) , and the mechanism(s) behind ET-1 production is not well understood. After hemorrhage, increases in [Ca 2ϩ ] i have been observed in major cerebral arteries, along with other vasoactive agents (8, 10, 17, 15, 40) . Accumulations of [Ca 2ϩ ] i in cerebral arteries after hemorrhage may play significant roles in the pathogenesis of hemorrhageinduced alterations of cerebral microcirculation, including ET-1 production and microvascular constriction, but the role of Ca 2ϩ in ET-1 biosynthesis is not known. In the present study, we investigated the hypothesis that breakdown products of blood stimulate influx of Ca 2ϩ into cerebral microvascular endothelial cells via voltage-dependent Ca 2ϩ channels and that this influx plays a role in increasing ET-1 biosynthesis.
METHODS

Primary Culture of Cerebral Microvascular Endothelial Cells
Primary cultures of cerebral microvascular endothelial cells from newborn pig brain cortex were established as previously described (12, 23, 24, 35) . Briefly, cerebral cortical microvessels (60-300 m) were isolated by differential filtration of cerebral cortex homogenate, first through 300-m and then through 60-m nylon mesh screens. The isolated microvessels were incubated in collagenase-dispase solution (1 mg/ml) for 2 h at 37°C. At the end of the incubation, the dispersed microvascular endothelial cells were separated by using Percoll density gradient centrifugation. Endothelial cells were resuspended in culture medium consisting of 20% fetal bovine serum (20% FBS), 2 mg/ml sodium bicarbonate, 1 U/ml heparin, 30 mg/ml endothelial cell growth supplement, 100 U/ml penicillin, 100 mg /ml streptomycin, and 2.5 mg/ml amphotericin B. Endothelial cells were plated on 12well Costar plates coated with Matrigel. Endothelial cell cultures were maintained in a 5% CO 2/air incubator at 37°C. The culture medium was changed frequently until the cells attained confluence (after 5-7 days of cultivation). At confluence, the cells were serum deprived by decreasing the medium concentration of fetal calf serum to 0.5% for at least 24 h before they were used for the experiments.
We showed previously that our primary cultures of cerebral microvascular endothelial cells were more than 95% endothelial cells with typical endothelial cell characteristics (12, 23, 24) . The endothelial cells we used display densitydependent inhibition of proliferation, form strict monolayers, and require endothelial growth supplement for survival. The cells express factor VIII and retain the elongated phenotype characteristic of microvascular endothelial cells. They are polarized directionally to specific transport. The cells maintain physiological responsiveness to stimuli and increase prostaglandin production in response to hypercapnia and bradykinin (12, 23, 24) .
Determination of the Role of Extracellular Ca 2ϩ in ET-1 Production by Endothelial Cells
ET-1 production by confluent endothelial cells was measured after 4 h of treatment with medium (control), thromboxane analog, U-46619 (1 M), 5-HT (0.1 mM), or LPA (1 M). At the end of the incubation, the medium and cells scraped from the plate were collected and stored at Ϫ70°C. To investigate the role of extracellular Ca 2ϩ in the regulation of ET-1 production by these potential vasoconstrictor agents, endothelial cells were pretreated for 15 min with either Ca 2ϩ -chelating agent EDTA (100 mM), the L-type Ca 2ϩ channel blocker verapamil (10 M), or 10 M SKF-96365 HCl {1-[b-[3-(4-methoxyphenyl) propoxy]-4-methoxyphenethyl]-1H-imidazole HCl}, a receptor-operated Ca 2ϩ channel antagonist. In the continued presence of EDTA, verapamil, or SKF-96365, the cells were then exposed to U-46619, 5-HT, or LPA for 4 h. At the end of the incubation, medium and cells were collected and stored at Ϫ70°C until assayed.
ET-1 Assay
ET-1 was measured in the collected medium by using radioimmunoassay [ET-1, 2 specific radioimmunoassay (RIA) kit; Amersham Life Sciences, Arlington Heights, IL], according to the manufacturer's instructions. The system utilizes a high specific activity of 125 I-labeled ET-1 synthetic tracer, together with a highly specific and sensitive antiserum. Separation of the bound antibody from the free fraction was achieved with the addition of an Amerlex-M second antibody preparation to the reaction mixture (unknown, antibody, and 125 I-ET-1) which was incubated for 16-24 h at 2-8°C (overnight delay addition protocol). The mixture was centrifuged at 3,000 rpm at 16°C for 15 min. The supernatant was then removed by vacuum suction, and radioactivity in the pellet was determined in a gamma counter. The concentration of the unlabeled ET-1 in the sample was determined by interpolation from the standard curve (0.25-32 fmol/tube). The sensitivity, as determined by 50% displacement of tracer, was 4.5 fmol.
Measurement of Cytosolic Ca 2ϩ
Cerebral microvascular endothelial cells were planted on Matrigel-coated plastic Aclar cover slips (Allied Engineered Plastics) and grown to confluence. At confluence, the cells were serum deprived by decreasing the medium concentration of fetal calf serum to 0.5% for at least 24 h. Cells were loaded with 4 mM fura 2-AM for 30 min at 37°C in serum-free medium. At the end of the incubation, the coverslips were inserted diagonally into the quartz cuvettes and perfused with Krebs buffer (in mM): 120 NaCL, 5 KCL, 0.62 MgSO 4, 1.8 CaCl2, 10 HEPES, and 6 glucose, pH 7.4, at 37°C. [Ca 2ϩ ]i was determined by measuring fluorescence of Ca 2ϩ /fura 2 with a Perkin Elmer luminescence spectrometer (model LS 50B) at excitation wavelengths of 340 and 380 nm, and emission was monitored at 510 nm.
Statistics
All experiments for ET-1 production were conducted in triplicate, and the means were used as data points. There was minimal variation in protein concentration among wells, and the results were corrected for protein concentration and expressed as femtomoles per microgram of protein. Values for ET-1 production are presented as means Ϯ SE. The results were subjected to two-way analysis of variance (ANOVA) for repeated measures with Fisher PLSD to isolate differences between groups. A level of P Ͻ 0.05 was considered significant. The results presented for the measurement of [Ca 2ϩ ]i signal are representative of at least three similar results.
Reagents EDTA, 5-HT, verapamil, nifedipine, and bradykinin were purchased from Sigma Chemical (St. Louis, MO), LPA was purchased from Avanti Polar Lipids (Alabaster, AL), and SKF-963365 was purchased from Calbiochem (San Diego, CA). ET-1 RIA kits were purchased from Amersham Life Sciences. Cell culture reagents were obtained from Life Technologies (Gaithersburg, MD) and Sigma. Matrigel (growth factor reduced) was purchased from Becton Dickinson (Bedford, MA). Fetal bovine serum was purchased from Hyclone.
RESULTS
Effects of Regulation of Ca 2ϩ on ET-1 Production
Incubation of cerebral microvascular endothelial cells in culture with U-46619 (1 M), 5-HT (0.1 mM), or LPA (1 M) for 4 h significantly increased ET-1 production compared with PBS control. The increased production of ET-1 in response to all of these agents was significantly attenuated in the presence of the Ca 2ϩ -chelating agent EDTA (0.1 M; Fig. 1 ). Similarly, 15 min of pretreatment of cells with the L-type Ca 2ϩ channel blocker verapamil (10 M) attenuated elevations of ET-1 production ( Fig. 2 ). In addition, we investigated the effects of blocking receptor-operated Ca 2ϩ channels on U-46619-(1 M), 5-HT-(0.1 mM), or LPA-(1 M) induced elevations of ET-1 biosynthesis. Treatment of confluent endothelial cells with SKF-96365 HCl (10 M), a receptor-operated Ca 2ϩ channel blocker, prevented the elevations of ET-1 production ( Fig. 3 ).
Regulation of [Ca 2ϩ ] i in Cultured Cerebral Microvascular Endothelial Cells
Effects of U-46619, LPA, and 5-HT on [Ca 2ϩ ] i . Figure  4 (Fig. 5 ). This observation indicates that U-46619 can increase [Ca 2ϩ ] i through Ca 2ϩ release from intracellular Ca 2ϩ stores, as well as through Ca 2ϩ channels.
Roles of voltage-dependent channels in vasoactive agent-induced [Ca 2ϩ ] i signals. Verapamil, a voltagedependent Ca 2ϩ channel blocker, and SKF-96365, a receptor-operated Ca 2ϩ channel blocker, attenuate ET-1 production by endothelial cells (see Figs. 1 and  2) .These results suggest that both voltage-and receptor-operated Ca 2ϩ channels may be involved in the regulation of [Ca 2ϩ ] i and ET-1 production by endothelial cells. We therefore investigated the effects of membrane depolarization with high K ϩ (60 mM) on increases in [Ca 2ϩ ] i induced by vasoactive agents. Effects of depolarization on vasoactive agent-induced increases in [Ca 2ϩ ] i were determined in confluent cells after perfusion of cells with high K ϩ . Depolarization of confluent endothelial cells by high K ϩ diminished increases in [Ca 2ϩ ] i by 5-HT (0.1 mM) or bradykinin (1 M). After perfusion of endothelial cells with high K ϩ , increased basal intracellular [Ca 2ϩ ] i was observed (Fig. 6, A and B) . The results presented (Fig. 6, A and  B) suggest that [Ca 2ϩ ] i signals induced by vasoactive agents in cerebral microvascular endothelial cells involve voltage-operated Ca 2ϩ channels. However, in the presence of membrane depolarization, Ca 2ϩ responses to 5-HT or bradykinin applications were not completely abolished. Persistence of agonist-induced increases in cytosolic Ca 2ϩ observed (Fig. 6 ) in the presence of high K ϩ may be due to either Ca 2ϩ release or Ca 2ϩ influx via channels other than voltage-operated channels.
Next, we investigated the effects of blocking L-type voltage-operated Ca 2ϩ channels pharmacologically on the [Ca 2ϩ ] i responses to these vasoactive agents. Confluent endothelial cells were pretreated with specific L-type voltage-operated Ca 2ϩ channel blocker nifedipine (4 M), and the effects of the pretreatment were determined on the 5-HT and bradykinin-induced elevation of [Ca 2ϩ ] i (Fig. 7, A and B) . Pretreatment of endothelial cells with nifedipine diminished bradykinin and 5-HT-induced elevations of [Ca 2ϩ ] i . This result further shows that the mechanism mediating the vasoactive agents' induced increase in endothelial cell [Ca 2ϩ ] i involves the L-type voltage-operated, as well as receptor-operated, Ca 2ϩ channels. These data also suggest that voltage-operated Ca 2ϩ channels are expressed in primary culture of cerebral microvascular endothelial cells. In the presence of nifedipine, Ca 2ϩ signals in response to bradykinin but not 5-HT application were not completely blocked. This could be due to Ca 2ϩ entry via channels other than voltage-operated and/or effects of nifedipine causing Ca 2ϩ release from an internal store (25) . The latter is unlikely because the same was not observed after application of 5-HT. The Ca 2ϩ signals observed may be due to activation of other bradykinin-sensitive (nifedipine-insensitive) ion channels present in endothelial cells (20) .
Effects of repeated applications of vasoactive agents on [Ca 2ϩ ] i signal.
To determine whether increases in [Ca 2ϩ ] i in response to vasoactive agents are reproducible overtime, cells were stimulated twice with brady-kinin (1 M) or 5-HT (0.1 mM). The second application of bradykinin or 5-HT produced Ca 2ϩ signals that were similar to those observed after the first application (Fig. 8, A and B) . In another experiment, we determined the effects of exposure of endothelial cells to high K ϩ on Ca 2ϩ -signaling responses to application of vasoactive agents. After the effect of high K ϩ on the Ca 2ϩ -signaling responses to bradykinin or 5-HT were determined, the endothelial cells were perfused with normal Krebs buffer to wash out the high K ϩ . Then effects of the prior exposure to high K ϩ on Ca 2ϩsignaling responses to repeated applications of bradykinin or 5-HT were determined. The repeated applications of bradykinin or 5-HT resulted in increased [Ca 2ϩ ] i -signaling responses which were greater than those observed in the presence of high K ϩ and comparable to responses elicited under control conditions. These observations showed reversibility of the effects of depolarization on Ca 2ϩ -signaling responses (Fig. 8,  C and D) . In addition, repeated applications of bradykinin did not result in any significant attenuation of responses. These results showed that repeated application of vasoactive agents did not result in significant desensitization of the Ca 2ϩ -signaling responses and that the attenuation of responses observed after high K ϩ were due to the effects of depolarization.
DISCUSSION
The novelty of our present findings are that 1) cerebral microvascular endothelial cells in primary culture express receptor-operated and L-type voltage-dependent Ca 2ϩ channels, 2) breakdown products of blood induce elevation of [Ca 2ϩ ] i in endothelial cells via activation of both receptor-and voltage-operated Ca 2ϩ channels, and 3) increases in ET-1 production from cerebral microvascular endothelial cells caused by structurally dissimilar vasoactive agents found in blood hemolysates are attenuated by Ca 2ϩ -free medium, L-type voltage-dependent, and receptor-operated Ca 2ϩ channel blockade.
One of the important findings of the present study among others is the expression of L-type voltage-gated Ca 2ϩ channel in cerebral microvascular endothelial cells. The presence of voltage-gated Ca 2ϩ channel in endothelial cell is very important for many reasons and has wide implications. Endothelial cells form a unique signal transduction surface in the vascular system, as well as provide a pathway for delivery of oxygen from blood to tissue and production and release of vasoactive factors, e.g., nitric oxide, prostacyclin, and endothelin. Ca 2ϩ channels have been implicated in the modulation of endothelial function and may be involved in the trafficking of macromolecules by endocytosis, the biosynthetic secretory pathway, and exocytosis. Ion channels are also implicated in controlling endothelial proliferation and angiogenesis. These functions have been shown to be triggered via ion channels which either provide Ca 2ϩ entry pathways or provide the driving force for Ca 2ϩ influx through these pathways. Endothelial cells modulate the tone of vascular smooth muscle cells via release of vasoactive agents, which in turn control blood pressure and blood flow (20) . But the presence of voltage-gated ion channels in endothelial cells (a nonexcitable cell) has been difficult to reconcile with the slow and often small changes in membrane potential. However, incidences of low-current voltagegated ion channels in both freshly isolated and cultured endothelial cells have been reported. About 50% of these channels are said to be inactivated at normal resting potential (20) . It is therefore possible that because of the low density and current, the detection of voltagegated ion channels has been difficult in endothelial cells. Thus the presence of voltage-gated Ca 2ϩ channels in endothelial cells may be important for endothelial functions and have wide implications because the channels could play a significant role in the physiology and pathology of vascular systems. However, the presence of L-type voltage-gated Ca 2ϩ channels in endothelial cells has been a source of controversy. Although lack of voltage-gated Ca 2ϩ channels has been reported in endothelial cells isolated from pig coronary artery (32) or rabbit and rat aorta (19) , the presence of voltage-gated Ca 2ϩ channels has been demonstrated in freshly isolated capillary endothelial cells from bovine adrenal glands (5, 6) . The differences reported in the expression of voltage-gated Ca 2ϩ channels in endothelial cells could be due to the methods used in cell isolation, the origin of cells used (isolation from microvessels or macrovessels), or even the species. The origin of the endothelial cells could significantly influence the types of ion channels expressed by the endothelial cells. Microvessels and macrovessels play different roles in the vascular system and, as such, may vary considerably in their expression of ion channels. The functions of conductance and resistance vessels in the vascular systems are different and could influence the channels that are expressed in the endothelial cells. Hence, the expression of voltage-gated Ca 2ϩ channels in endothelial cells could be vessel and function specific. The resistance vessels play important roles in the regulation of systemic blood flow and perfusion of end organs. The functional roles of the voltage-dependent Ca 2ϩ channels involve the production and release of many vasoactive endothelial factors that regulate vascular tone, as well as control of macromolecular trafficking such as endocytosis, exocytosis, biosynthetic secretory pathway, and transcytosis (20) . Voltage-gated Ca 2ϩ channels are responsible for the long-lasting increases in free [Ca 2ϩ ] i during different stimuli and provide the signals for maintaining endothelial functions (2, 4, 20) . In the present study, we have shown results from confluent, highly homogenous, and fully differentiated primary culture of cerebral microvascular endothelial cells that are consistent with the presence of L-type voltage-gated Ca 2ϩ channels. Cells in culture can behave differently from those under in vivo conditions, depending on the condition of culture (3-6, 20, 32) , so we used young primary cultures of endothelial cells that we had shown to retain their endothelial characteristics to minimize such differences (23, 24) .
ET-1 is one of the most important vascular endothelial factors produced, and its biosynthesis could be controlled by intracellular Ca 2ϩ signals, especially after cerebral hemorrhage. Intracellular Ca 2ϩ signals result from stimulation of cells by vasoactive agents. Such signals can result from opening of plasma membrane Ca 2ϩ channels or Ca 2ϩ release from intracellular stores or both. Interactions of vasoactive agents with their receptors can directly activate Ca 2ϩ channels, as well as initiate Ca 2ϩ release from intracellular stores. Activation of plasma membrane receptors can lead to the generation of IP 3 , a known cytosolic messenger linking hormone-receptor interaction to intracellular Ca 2ϩ release (2, 3, 16, 20) . The elevated intracellular Ca 2ϩ concentration could lead to the opening of Ca 2ϩ channels, resulting in influx of extracellular Ca 2ϩ . The role of elevated calcium ions in the stimulation of ET-1 production from cerebral microvascular endothelial cells is not yet clear. We have shown that regulation of [Ca 2ϩ ] i affects ET-1 biosynthesis from endothelial cells by vasoactive agents and that these vasoactive agents are capable of elevating [Ca 2ϩ ] i via both receptor-and voltage-operated Ca 2ϩ channels, but the mechanism by which such elevation in [Ca 2ϩ ] i regulates ET-1 synthesis is still not known. ET-1 is known to be synthesized de novo, with production being regulated at the mRNA transcriptional and translation level (28, 38, 39) . Endothelin gene transcriptions are modulated by various factors, such as thrombin, angiotensin II, phorbol ester, shear stress, and calcium ionophore (13, 21 28, 38, 39) . It is probable that elevated intracellular Ca 2ϩ induced by blood clot-derived agents can modulate ET-1 gene transcription at the mRNA level. ET-1 is produced from a 203 amino acid protein precursor preproendothelin-1, which is converted to big ET-1, a 39 amino acid precursor peptide, by endopeptidase. The big ET-1 is converted to the mature ET-1 by a novel protease, endothelin-converting enzyme (ECE). Processing of big ET-1 to ET-1 is essential for full expression of biological activity (13, 21 28, 38, 39) . Therefore, the step involving ECE is a rate-limiting step for ET-1 production and could be a target for regulation by the blood clot-derived vasoactive agents via elevated cytosolic Ca 2ϩ . Whether or not ECE is a Ca 2ϩ -dependent enzyme is uncertain. Elevated Ca 2ϩ has been shown to activate specific transcription factors (4, 29), but whether there is a particular transcription factor for ET-1 production susceptible to activation by elevated intracellular Ca 2ϩ is not known. Certainly, our results are consistent with studies that suggest that Ca 2ϩ entry is required for ET-1 release from human coronary endothelial cultures (10) .
The route of Ca 2ϩ entry into the cell can determine the particular transcription factors that are activated (4, 29) . Bading et al. (1) have demonstrated that Ca 2ϩ entry through the voltage-dependent L-type Ca 2ϩ channels and N-methyl-D-aspartate (NMDA) receptors initiate gene transcription through distinct DNA regulatory elements. This might be the case in the present study in which we have shown that elevated Ca 2ϩ observed in cerebral microvascular endothelial cells is mediated via receptor-as well as voltage-dependent Ca 2ϩ channels. Hence, the increase in ET-1 biosynthesis induced by the clot-derived vasoactive agents via elevated intracellular Ca 2ϩ may be mediated through activation of a specific transcription factor for ET-1 biosynthesis [possibly through activation of the gene(s) for the production of the numerous enzymes involved in ET-1 synthesis].
In the present study, we used the specific L-type voltage-gated Ca 2ϩ channel blocker nifedipine, and, consistent with the presence of the L-type Ca 2ϩ channel, nifedipine diminished the vasoactive agent-induced Ca 2ϩ signal in endothelial cells. However, others have reported that nifedipine can increase [Ca 2ϩ ] i by activation of Ca 2ϩ release from intracellular store in smooth muscle cells and extracellular Ca 2ϩ influx in coronary endothelial cells (3, 25) . The intracellular effects of nifedipine reported may be due to high concentration (10 M) or to the cell type used in the study. Although Raicu and Florea (25) used smooth muscle cells and 10 M nifedipine, Berkels et al. (3) used coronary endothelial cells. Hence, such effects of nifedipine could be cell selective and may induce effects other than the selective blockade of the L-type Ca 2ϩ channel. In the present study, we did not observe any increase in [Ca 2ϩ ] i upon nifedipine treatment.
In conclusion, elevated intracellular Ca 2ϩ plays a significant role in the increased production of ET-1 caused by specific spasmogenic agents. Ca 2ϩ signaling and ET-1 production could be involved in hemorrhageinduced alteration of cerebral microvascular reactivities and development of vasospasm. The presence of voltage-gated calcium channels in endothelial cells has wide implications. Pharmacological manipulation of the L-type voltage-gated calcium channel in many cases is readily accomplished and is also of therapeutic significance. L-type channels are very accessible to pharmacological modification and could be manipulated to influence release of mediators of endotheliumdependent relaxing and contracting factors.
